Integrating quantitative and qualitative data and findings when undertaking randomised controlled trials.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
26 11 2019
Historique:
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 20 11 2020
Statut: epublish

Résumé

It is common to undertake qualitative research alongside randomised controlled trials (RCTs) when evaluating complex interventions. Researchers tend to analyse these datasets one by one and then consider their findings separately within the discussion section of the final report, rarely integrating quantitative and qualitative data or findings, and missing opportunities to combine data in order to add rigour, enabling thorough and more complete analysis, provide credibility to results, and generate further important insights about the intervention under evaluation. This paper reports on a 2 day expert meeting funded by the United Kingdom Medical Research Council Hubs for Trials Methodology Research with the aims to identify current strengths and weaknesses in the integration of quantitative and qualitative methods in clinical trials, establish the next steps required to provide the trials community with guidance on the integration of mixed methods in RCTs and set-up a network of individuals, groups and organisations willing to collaborate on related methodological activity. We summarise integration techniques and go beyond previous publications by highlighting the potential value of integration using three examples that are specific to RCTs. We suggest that applying mixed methods integration techniques to data or findings from studies involving both RCTs and qualitative research can yield insights that might be useful for understanding variation in outcomes, the mechanism by which interventions have an impact, and identifying ways of tailoring therapy to patient preference and type. Given a general lack of examples and knowledge of these techniques, researchers and funders will need future guidance on how to undertake and appraise them.

Identifiants

pubmed: 31772096
pii: bmjopen-2019-032081
doi: 10.1136/bmjopen-2019-032081
pmc: PMC6886933
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e032081

Subventions

Organisme : Medical Research Council
ID : MR/L004933/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800792
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU15
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/15
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0901335
Pays : United Kingdom
Organisme : Department of Health
ID : HPRU-2012-10041
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K025635/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K025643/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L004933/2
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2018 Aug 10;8(8):e021605
pubmed: 30099395
BMJ Open. 2019 May 29;9(5):e023873
pubmed: 31147359
BMJ Open. 2013 Jun 20;3(6):null
pubmed: 23794542
BMJ. 2009 Sep 10;339:b3496
pubmed: 19744976
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Lancet. 2013 Oct 5;382(9899):1175-82
pubmed: 23915885
Qual Health Res. 2006 Mar;16(3):377-94
pubmed: 16449687
Support Care Cancer. 2015 May;23(5):1261-71
pubmed: 25322972
Implement Sci. 2016 May 12;11:66
pubmed: 27175799
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
BMJ. 2010 Sep 17;341:c4587
pubmed: 20851841
Ann Fam Med. 2015 Nov;13(6):554-61
pubmed: 26553895

Auteurs

David A Richards (DA)

Institute of Health Sciences, College of Medicine and Health, University of Exeter, Exeter, Devon, UK D.A.Richards@exeter.ac.uk.

Patricia Bazeley (P)

Transitional Research and Social Innovation Group, Western Sydney University, Penrith South, New South Wales, Australia.

Gunilla Borglin (G)

Department of Care Science, Malmo University, Malmo, Skåne, Sweden.
Department of Nursing Education, Lovisenberg Diaconal University College, Oslo, Akershus, Norway.

Peter Craig (P)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, Glasgow, UK.

Richard Emsley (R)

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, London, UK.

Julia Frost (J)

Institute of Health Sciences, College of Medicine and Health, University of Exeter, Exeter, Devon, UK.

Jacqueline Hill (J)

Institute of Health Sciences, College of Medicine and Health, University of Exeter, Exeter, Devon, UK.

Jeremy Horwood (J)

Population Health Sciences, University of Bristol, Bristol, Bristol, UK.

Hayley Anne Hutchings (HA)

Medical School, Swansea University, Swansea, West Glamorgan, UK.

Clare Jinks (C)

School of Primary, Community and Social Care, Keele University, Keele, Staffordshire, UK.

Alan Montgomery (A)

Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, Nottinghamshire, UK.

Graham Moore (G)

School of Social Sciences, Cardiff University, Cardiff, South Glamorgan, UK.

Vicki L Plano Clark (VL)

School of Education, University of Cincinnati College of Education Criminal Justice and Human Services, Cincinnati, Ohio, USA.

Sarah Tonkin-Crine (S)

Department of Primary Care Health Sciences, and NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, Oxfordshire, UK.

Julia Wade (J)

Population Health Sciences, University of Bristol, Bristol, Bristol, UK.

Fiona C Warren (FC)

Institute of Health Sciences, College of Medicine and Health, University of Exeter, Exeter, Devon, UK.

Sally Wyke (S)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, Glasgow, UK.

Bridget Young (B)

Institute of Population Health Sciences, University of Liverpool, Liverpool, Merseyside, UK.

Alicia O'Cathain (A)

Medical Care Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH